Lucas M. Kimmig

Lucas Kimmig practices at The University of Chicago Medical Center in Chicago, Illinois.

Lucas Kimmig's NPI, 1346500576, was assigned on May 22, 2012. Lucas Kimmig holds Illinois license 036140397.

Lucas Kimmig's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Lucas Kimmig's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Lucas Kimmig is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Lucas Kimmig to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lucas Kimmig practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Lucas Kimmig's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Lucas Kimmig is licensed in Illinois.

CMS data shows 272 Medicare services from Lucas Kimmig across 6 procedure codes in 2024, for 203 Medicare patients. Medicare paid $32,871 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 203 Medicare patients who saw Lucas Kimmig in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lucas Kimmig's median patient age at 72, with 64% women.

In 2024, Lucas Kimmig wrote 434 Medicare Part D claims for 93 patients. 26% of them were for generic drugs. CMS names the drug for 349 of them, across 13 drugs with 11 or more claims each, at $188,730 in total drug cost. In 2023, CMS named 233 claims across 10 drugs.

Lucas Kimmig accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lucas Kimmig as offering telehealth.

Dmand AI links 19 papers to Lucas Kimmig, published from 2013 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Macrophages, Alveolar, Lung and COVID-19. Lucas Kimmig has published most often in Ann Am Thorac Soc. Lucas Kimmig's most frequent co-authors are David L. Pitrak, MD, Remzi Bag and Ece A. Mutlu, MD.

CMS Open Payments shows 14 general payments to Lucas Kimmig from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $158.